Related Experiment Video
Updated: Aug 3, 2025
11:22
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
8.0K
[Gene Therapy for Huntington Disease]
Stefan Bräuer1, Björn Falkenburger1
1Klinik und Poliklinik für Neurologie, Universitätsklinikum an der TU Dresden, Dresden, Germany.
Fortschritte Der Neurologie-Psychiatrie
|April 11, 2023
Summary
Huntington's disease gene therapy is advancing, with antisense oligonucleotides being the most developed. Recent trials show promise but highlight challenges in developing effective treatments for this neurodegenerative disease.
Area of Science:
- Neurodegenerative diseases
- Genetics
- Gene therapy
Context:
- Huntington's disease is a common genetic neurodegenerative disorder.
- It serves as a model for gene therapy research.
- Current research focuses on RNA and DNA-level interventions.
Purpose:
- To review advanced gene therapy options for Huntington's disease.
- To discuss the status of clinical trials and therapeutic strategies.
- To analyze the implications of recent trial results.
Summary:
- Antisense oligonucleotides represent the most advanced gene therapy approach for Huntington's disease.
- Other strategies include micro-RNAs, RNA splicing modulators, and zinc finger proteins.
- Clinical trials are exploring different application methods, systemic availability, and targeted approaches (e.g., exon1 protein).
- The GENERATION HD1 trial's termination due to side effects underscores the complexities of Huntington's disease gene therapy development.
Impact:
- Provides an overview of cutting-edge gene therapy research for Huntington's disease.
- Highlights the challenges and potential of various therapeutic strategies.
- Informs future research directions by analyzing recent clinical trial outcomes.
More Related Videos
Related Concept Videos
00:59Gene Therapy
25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
01:22Alzheimer's Disease: Treatment
232
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
232
01:24Parkinson's Disease: Treatment
317
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
317
01:16In-vitro Mutagenesis
14.1K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.1K
00:49What is Genetic Engineering?
74.5K
Overview
74.5K